免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

臨床試験

Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation

NCT: NCT05090540 · ENROLLING_BY_INVITATION

NCT識別子NCT05090540
ステータスENROLLING_BY_INVITATION
開始日2017-06-01
完了2026-12-30
SponsorCentre Cardiologique du Nord (OTHER)
First posted
Last updated

概要

The mechanical intervention is treating secondary mitral regurgitation (SMR) which may be performed using the standard open surgical approach or transcatheter edge to edge repair (TEER). The key question of this study is to establish the difference in left ventricular reverse remodeling after adjustment for death, as assessed by means of the left ventricular end-systolic dimension(LVESD), all-cause and cause-specific (cardiac vs noncardiac) mortality in patients who received the TEER vs the standard surgical procedure for SMR.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。

↑